Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PerioGard Regimen vs Control in Reducing Plaque and Gingivitis
NCT07210138Phase 3Completed
- Sponsor
- Colgate-Palmolive
- Start
- Aug 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of petrolatum in gingivitis and dental plaque (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Loe-Silness Gingival Index at 12 weeks and Quigley-Hein Plaque Index at 12 weeks. Started Aug 2025; status: completed.
02
Drugs
petrolatum
03
Conditions
gingivitisdental plaque
Beyond the preview
Go deeper on NCT07210138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07210138.